Acusensus Ltd (ACE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 64.83K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.31
• Revenue Growth: 14.44%
• EPS Growth: -2450.00%
• Country: AU
• Employees: 164
• Sector: Technology
• Sector Strength: 69
• Industry: Software - Infrastructure
• EPS (TTM): -0.01
• Shares Outstanding: 140,025,860
• 10 Day Avg. Volume: 19,333
• 30 Day Avg. Volume: 64,833
• PEG Ratio: 4.09
• Price to Book (P/B): 2.68
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 116.52
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.37
• Price Target Upside: 37.00% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

Acusensus Ltd exhibits impressive revenue growth and a strong balance sheet, but profitability remains a key challenge. Technical indicators suggest mixed momentum, while the negative P/E ratio highlights valuation concerns. Continued focus on enhancing profitability and cash flow is essential for improving its stock appeal.

Acusensus Ltd Business Overview & Revenue Model

Company Description

Acusensus Ltd (ACE) is a technology company specializing in intelligent transport solutions. The company develops and implements advanced systems for road safety enforcement and traffic management. Its core products include automated camera enforcement systems and data analytics platforms designed to enhance road safety and efficiency.

How the Company Makes Money

Acusensus Ltd generates revenue primarily through the sale and deployment of its intelligent transport solutions. Key revenue streams include the sale of automated camera enforcement systems to government and municipal authorities, as well as ongoing service contracts for system maintenance and support. The company may also engage in partnerships with transport agencies to provide comprehensive data analytics services, contributing to enhanced traffic management and safety initiatives. Revenue is further supported by licensing agreements for proprietary technologies and software platforms.

Acusensus Ltd Financial Statement Overview

Summary

Acusensus Ltd is experiencing strong top-line growth, but challenges in profitability and free cash flow generation remain. A robust balance sheet with low leverage provides a stable foundation, but sustained efforts to enhance operational efficiency and profitability are necessary to realize the full potential of its growth trajectory.

Income Statement

Acusensus Ltd has shown impressive revenue growth, with a significant increase from $2.27M in 2020 to $49.63M in 2024. However, profitability remains a challenge, as reflected in the negative EBIT and net income margins in the latest year. The gross profit margin has improved over time, indicating better cost management. Sustained focus on converting revenue growth into profit will be crucial.

Balance Sheet

The balance sheet is stable with a high equity ratio of 73.8% in 2024, indicating strong capitalization. The debt-to-equity ratio is low at 0.06, suggesting minimal leverage risk. However, consistent net losses have pressured equity growth. Improving profitability could further strengthen the balance sheet.

Cash Flow

Operating cash flow remains positive, reflecting operational efficiency. However, free cash flow is negative due to high capital expenditures, impacting liquidity. The free cash flow to net income ratio is negative, indicating a need to align capital spending with cash generation to improve cash flow stability.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
53.68M	49.63M	42.00M	28.65M	6.27M	2.27M
	Gross Profit
25.05M	22.58M	4.61M	3.21M	-1.18M	1.10M
	EBIT
1.83M	-1.99M	1.01M	1.20M	-3.49M	-1.35M
	EBITDA
3.60M	5.39M	5.35M	4.38M	-2.97M	-1.22M
	Net Income Common Stockholders
-1.79M	-1.52M	55.37K	1.43M	-3.65M	-1.25M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
21.15M	19.34M	24.80M	8.61M	12.33M	1.11M
	Total Assets
46.93M	48.69M	48.46M	26.16M	19.57M	3.42M
	Total Debt
1.68M	2.19M	2.19M	2.33M	780.98K	0.00
	Net Debt
-7.47M	-5.15M	-10.61M	-6.28M	-11.55M	-1.11M
	Total Liabilities
10.54M	12.77M	12.54M	9.40M	4.50M	714.00K
	Stockholders Equity
36.39M	35.92M	35.92M	16.76M	15.07M	2.65M
Cash Flow		Free Cash Flow
1.21M	-3.94M	-1.12M	-2.28M	-3.85M	-2.16M
	Operating Cash Flow
9.43M	3.58M	4.26M	4.97M	-1.00M	-1.44M
	Investing Cash Flow
-18.38M	-7.52M	-17.37M	-7.24M	-3.17M	-839.00K
	Financing Cash Flow
9.86M	-1.47M	17.34M	-1.44M	15.38M	2.25M

Acusensus Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ACE, the sentiment is Negative. The current price of 1 is below the 20-day moving average (MA) of 1.00, below the 50-day MA of 1.05, and above the 200-day MA of 0.95, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.87 is Neutral, neither overbought nor oversold. The STOCH value of 41.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ACE.

Acusensus Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WTC	78 Outperform	$32.49B	128.92	14.13%	0.20%	-1.78%	12.79%
TNE	70 Outperform	€10.35B	87.25	34.02%	0.77%	17.97%	14.29%
CPU	65 Neutral	$23.00B	22.05	27.30%	2.27%	-0.84%	93.59%
REA	62 Neutral	$31.90B	51.69	37.91%	0.88%	20.28%	118.95%
Sector *	60 Neutral	$11.39B	10.52	-6.21%	2.95%	7.68%	-11.12%
ACE	58 Neutral		―	-4.25%	―	14.44%	-2450.00%
APX	50 Neutral	$249.72M	―	-19.32%	―	-13.61%	86.37%

Acusensus Ltd Corporate Events

Acusensus Ltd Announces Cessation of Performance Rights

Acusensus Ltd announced the cessation of 93,136 performance rights due to the lapse of conditional rights, as the conditions for these securities were not met by the deadline of March 31, 2025. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and financial strategy.

Acusensus Ltd Issues New Unquoted Equity Securities

Acusensus Ltd has announced the issuance of 92,820 unquoted equity securities, which are ordinary fully paid shares. This move, effective from May 3, 2025, involves the conversion of unquoted options or other convertible securities. The announcement reflects Acusensus’s ongoing financial activities and could potentially impact its market position by increasing its equity base.

Acusensus Ltd Announces Quotation of New Securities on ASX

Acusensus Ltd has announced the quotation of 92,820 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code ACE. This move is part of an employee incentive scheme, reflecting the company’s efforts to enhance employee engagement and potentially improve its market positioning.

Acusensus Ltd Announces New Securities Quotation on ASX

Acusensus Ltd has announced the issuance of 25,000 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code ACE. This move signifies a strategic step for the company, potentially enhancing its market presence and providing additional capital for future growth initiatives.

Acusensus Reports Revenue Growth Amid Rising Losses

Acusensus Limited reported a 16.4% increase in revenue for the half-year ending December 31, 2024, reaching $28.8 million, driven by new contracts and expanded services. Despite revenue growth, the company experienced a 111.7% increase in operating loss to $511,000 due to higher operating expenses and investments aimed at future growth, impacting its financial performance.